Incidence and associated factors of cetuximab-induced hypersensitivity infusion reactions in 1392 cancer patients treated in four French areas: a possible association with Lyme disease?

BACKGROUND: Previous studies have observed an increased incidence of Cetuximab-induced hypersensitivity infusion reactions (CI-IRs) in the southeastern states of the USA. Tick’s bites were suspected of generating cross-reactions between cetuximab and alpha-gal. This study aims was to describe the in...

Descripción completa

Detalles Bibliográficos
Autores principales: Dupont, M, Carlier, Claire, Gower-Rousseau, C, Barbier-Lider, P, Botsen, D, Brasseur, M, Burgevin, A, Chourbagi, C, D’Almeida, R, Hautefeuille, V, Hentzien, M, Lambert, A, Lamuraglia, M, Lavau-Denes, S, Lopez, A, Parent, D, Slimano, F, Brugel, M, Bouché, O
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701068/
https://www.ncbi.nlm.nih.gov/pubmed/36434607
http://dx.doi.org/10.1186/s12885-022-10192-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701068/
https://www.ncbi.nlm.nih.gov/pubmed/36434607
http://dx.doi.org/10.1186/s12885-022-10192-4

Ejemplares similares